Articles dans des revues avec comité de lecture (4)
  1. 1. Bizerra, P. F. V., Gilglioni, E. H., Li, H. L., Go, S., Oude Elferink, R. R., Verhoeven, A. A., & Chang, J. C. (2024). Opposite regulation of glycogen metabolism by cAMP produced in the cytosol and at the plasma membrane. Biochimica et biophysica acta. Molecular cell research, 1871(1), 119585. doi:10.1016/j.bbamcr.2023.119585
  2. 2. Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C., Ramos-Molina, B., & Gurzov, E. N. (2023). Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports, 100811. doi:10.1016/j.jhepr.2023.100811
  3. 3. Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.101681
  4. 4. Brahma, M. K., Gilglioni, E. H., Zhou, L., Trepo, E., Chen, P., & Gurzov, E. N. (2021). Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges. Oncogene. doi:10.1038/s41388-021-01950-y